Immune-based therapies are transforming advanced liver cancer care, resulting in curative options previously considered ...
FLC is a rare liver cancer that affects approximately 500 people each year in the United States, typically healthy adolescents and young adults, explains lead study author Marina Baretti, M.D., an ...